Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 4/20 | 0.64 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.61 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.61 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.61 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.56 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.56 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | HTR2C | P28335 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | HRH1 | P35367 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.53 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Ethylhexanoic Acid SCHEMBL8375903 | 1.00 | CA2 (1.00) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| 2-Ethylhexanoic Acid SCHEMBL6121661 | 1.00 | CA2 (1.00) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| 2-Ethylhexanoic Acid SCHEMBL5695779 | 1.00 | CA2 (1.00) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| 2-Ethylhexanoic Acid SCHEMBL301319 | 1.00 | CA2 (1.00) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| 2-Ethylhexanoic Acid SCHEMBL25800 | 1.00 | CA2 (1.00) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| 2-Ethylhexanoic Acid SCHEMBL8387406 | 1.00 | CA2 (1.00) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| 2-Ethylhexanoic Acid SCHEMBL5512393 | 1.00 | CA2 (1.00) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| 2-Ethylhexanoic Acid SCHEMBL25318625 | 0.98 | CA2 (0.95) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| 2-Ethylhexanoic Acid SCHEMBL21054919 | 0.98 | CA2 (0.95) | CA2MAPK1CA1SLC1A2SLC1A1 | |
| 2-Ethylhexanoic Acid SCHEMBL21331330 | 0.98 | CA2 (0.95) | CA2MAPK1CA1SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | CORN PRODUCTS DEV INC (US) | 2026-02-05 | — | — | US | disclosed |
| EP-4561366-A1 | FLAVOR MODIFYING COMPOSITION | CORN Products Development Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| CN-119894387-A | Flavor modulating composition | 玉米产品开发公司 | 2025-04-25 | — | — | CN | disclosed |
| US-20250081996-A1 | FLAVOR MODIFYING COMPOSITION | PURECIRCLE SDN BHD (MY) | 2025-03-13 | — | — | US | disclosed |
| EP-4380375-A1 | METHODS FOR THERMALLY INHIBITING STARCH | CORN Products Development Inc. (US) | 2024-06-12 | — | — | EP | disclosed |
| CN-117835831-A | Flavor modulating composition | 玉米产品开发公司 | 2024-04-05 | — | — | CN | disclosed |
| WO-2024026450-A1 | FLAVOR MODIFYING COMPOSITION | CORN PRODUCTS DEVELOPMENT, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| US-20240024410-A1 | THREE-DIMENTIONAL SURFACE FOR PROTEIN AND SMALL MOLECULE MICROARRAYS | THE JOHNS HOPKINS UNIVERSITY | 2024-01-25 | — | — | US | disclosed |
| US-11840560-B2 | Prodrugs and uses thereof | NOVO NORDISK A/S (DK) | 2023-12-12 | — | — | US | disclosed |
| US-11708391-B2 | Rapaglutins, novel inhibitors of GLUT and use thereof | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-07-25 | — | — | US | disclosed |
| US-20090062366-A1 | Pyrrolidine derivative or salt thereof | ASTELLAS PHARAMA INC. (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090062366-A1 | Pyrrolidine derivative or salt thereof | ASTELLAS PHARAMA INC. (JP) | 2009-03-05 | — | — | US | disclosed |
| EP-1882684-A1 | PYRROLIDINE DERIVATIVE OR SALT THEREOF | Astellas Pharma Inc. (JP) | 2008-01-30 | — | — | EP | disclosed |
| WO-2007123631-A1 | POLYESTER COMPOSITIONS WHICH COMPRISE CYCLOBUTANEDIOL AND AT LEAST ONE PHOSPHORUS COMPOUND | EASTMAN CHEMICAL COMPANY (US) | 2007-11-01 | — | — | WO | disclosed |
| US-20070043114-A1 | Nerve regeneration promoters | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-02-22 | — | — | US | disclosed |
| US-20060211882-A1 | Method for producing optically active carboxylic acid | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1685832-A1 | NERVE REGENERATION PROMOTERS | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-08-02 | — | — | EP | disclosed |
| WO-2004087632-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-10-14 | — | — | WO | disclosed |
| US-20030049807-A1 | Micro-organism possessing enantioselective and regioselective nitrile hydratase/amidase activities | INSTITUTO BIOCHIMICO ITALIANO GIOVANNI LOREZINI S.P.A. (IT) | 2003-03-13 | — | — | US | disclosed |
| EP-1291435-A2 | A micro-organism possessing enantioselective and regioselective nitrile hydratase/amidase activities | ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. (IT) | 2003-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11840560-B2 | Prodrugs and uses thereof | GIPR, GLP1R, GRPR | CA2 2144/4885MAPK1 2486/4885CA1 1596/4885 |
| US-11708391-B2 | Rapaglutins, novel inhibitors of GLUT and use thereof | SLC2A1, SLC2A4, SLC2A2 | CA2 4074/4885MAPK1 1935/4885CA1 3660/4885 |
| US-20070043114-A1 | Nerve regeneration promoters | BDNF, NGF, GAP43 | CA2 4138/4885MAPK1 272/4885CA1 2621/4885 |
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | TAS2R42, TAS2R7, TAS2R31 | CA2 474/4885MAPK1 2601/4885CA1 832/4885 |
| US-20090062366-A1 | Pyrrolidine derivative or salt thereof | CASR, CYP2R1, PTH1R | CA2 138/4885MAPK1 1398/4885CA1 2553/4885 |
| US-20240024410-A1 | THREE-DIMENTIONAL SURFACE FOR PROTEIN AND SMALL MOLECULE MICROARRAYS | MRPS23, CD2BP2, MRPL21 | CA2 3837/4885MAPK1 2790/4885CA1 3462/4885 |
| US-20060211882-A1 | Method for producing optically active carboxylic acid | RARA, BROX, GRHPR | CA2 95/4885MAPK1 2968/4885CA1 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.